EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination

Nathalie Mantel iD, Fabienne Piras-Douce, Emilie Chautard, Ernesto Marcos-Lopez, Caroline L Bodinham, Antonio Cosma, Virginie Courtois, Nina Dhooge, Sylviane Gautheron, Stefan H E Kaufmann, Kathleen Pizzoferro, David J M Lewis und 5 weitere

Journal of Virology · 14.05.2024 · 98 (5)

DOI: 10.1128/jvi.01516-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 14.05.2024. Verfasst von Nathalie Mantel und 16 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Sanofi, Marcy L'Etoile, France. Hauptthemen laut MEDLINE: Macaca fascicularis, Yellow Fever Vaccine, Models, Animal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANR, Innovative Medicines Initiative Joint Undertaking.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The non-human primate (NHP) model (specifically rhesus and cynomolgus macaques) has facilitated our understanding of the pathogenic mechanisms of yellow fever (YF) disease and allowed the evaluation of the safety and efficacy of YF-17D vaccines. However, the accuracy of this model in mimicking vaccine-induced immunity in humans remains to be fully determined. We used a systems biology approach to compare hematological, biochemical, transcriptomic, and innate and antibody-mediated immune responses in cynomolgus macaques and human participants following YF-17D vaccination. Immune response progression in cynomolgus macaques followed a similar course as in adult humans but with a slightly earlier onset. Yellow fever virus neutralizing antibody responses occurred earlier in cynomolgus macaques [by Day 7[(D7)], but titers > 10 were reached in both species by D14 post-vaccination and were not significantly different by D28 [plaque reduction neutralization assay (PRNT) 50 titers 3.6 Log vs 3.5 Log in cynomolgus macaques and human participants, respectively; P = 0.821]. Changes in neutrophils, NK cells, monocytes, and T- and B-cell frequencies were higher in cynomolgus macaques and persisted for 4 weeks versus less than 2 weeks in humans. Low levels of systemic inflammatory cytokines (IL-1RA, IL-8, MIP-1α, IP-10, MCP-1, or VEGF) were detected in either or both species but with no or only slight changes versus baseline. Similar changes in gene expression profiles were elicited in both species. These included enriched and up-regulated type I IFN-associated viral sensing, antiviral innate response, and dendritic cell activation pathways D3–D7 post-vaccination in both species. Hematological and blood biochemical parameters remained relatively unchanged versus baseline in both species. Low-level YF-17D viremia (RNAemia) was transiently detected in some cynomolgus macaques [28% (5/18)] but generally absent in humans [except one participant (5%; 1/20)]. IMPORTANCE Cynomolgus macaques were confirmed as a valid surrogate model for replicating YF-17D vaccine-induced responses in humans and suggest a key role for type I IFN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macaca fascicularisYellow Fever VaccineModels, AnimalAnimalsFemaleHumansMaleAntibodies, NeutralizingAntibodies, ViralImmunity, InnateSystems BiologyVaccinationYellow FeverYellow fever virus

Stichwörter der Autor:innen

humannon-human primatevaccineyellow fever

Substanzen

Antibodies, NeutralizingAntibodies, ViralYellow Fever Vaccine

Autor:innen und Institutionen

  • Research and Development, Sanofi, Marcy L'Etoile, France.
  • Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay aux Roses, France.
  • Surrey Clinical Research Centre, University of Surrey, Guildford, Surrey, United Kingdom.
  • Max Planck Institute for Infection Biology, Berlin, Germany; Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Hagler Institute for Advanced Study, Texas A&M University, College Station, Texas, USA.

ORCID-Profile: Nathalie Mantel

Förderung

  • ANR
  • Innovative Medicines Initiative Joint Undertaking

Zitieren

APA

Mantel, N., Piras-Douce, F., Chautard, E., Marcos-Lopez, E., Bodinham, C. L., Cosma, A., Courtois, V., Dhooge, N., Gautheron, S., Kaufmann, S. H. E., Pizzoferro, K., Lewis, D. J. M., Martinon, F., Pagnon, A., Raynal, F., Dereuddre-Bosquet, N., & Le Grand, R. (2024). Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination. Journal of Virology, 98(5). https://doi.org/10.1128/jvi.01516-23

Vancouver

Mantel N, Piras-Douce F, Chautard E, Marcos-Lopez E, Bodinham CL, Cosma A, et al. Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination. Journal of Virology. 2024;98(5). doi:10.1128/jvi.01516-23

BibTeX
@article{Mantel2024,
  author = {Mantel, Nathalie and Piras-Douce, Fabienne and Chautard, Emilie and Marcos-Lopez, Ernesto and Bodinham, Caroline L and Cosma, Antonio and Courtois, Virginie and Dhooge, Nina and Gautheron, Sylviane and Kaufmann, Stefan H E and Pizzoferro, Kathleen and Lewis, David J M and Martinon, Frédéric and Pagnon, Anke and Raynal, Franck and Dereuddre-Bosquet, Nathalie and Le Grand, Roger},
  title = {Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {5},
  doi = {10.1128/jvi.01516-23}
}
Kostenlos starten →